Naos fund reaps life science and biotech rewards

Wed Apr 18, 2012

Read more:




Investments in Australian biotech and life sciences companies helped lift the Naos Emerging Long Short Equity Fund in March. The fund, which focuses exclusively on Australian equities, rose 9.33% in March, after a 11.83% gain in February.

"We don’t...

ISSN: 2151-1845 / CDC10004H

Register

By registering you will receive

  • A monthly newsletter on your specified areas of interest
  • A fortnightly update on the sector

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates


Popular Searches on HFI